TippingPoint Raises $4.5M Seed to Drug Hidden Epigenetic Targets in Deadly Pediatric Brain Cancer
For years, the biotech industry has poured billions into targeting epigenetic disease, only to run into the same wall. Most drugs go after catalytic pockets...